Postdoctoral Fellow John Chen in the Kampmann lab received a Research Fellowship from the Alzheimer's Association. Together with Diane Nathaniel, John investigates cellular pathways controlling the prion-like spread of tau aggregation, which is emerging as a key driver of disease progression in Alzheimer's Disease and other neurodegenerative diseases involving tau, including frontotemporal dementia. In his research, John combines CRISPR-based genetic screens with biochemistry and cell biology. The pathways identified in this project are potential therapeutic targets in Alzheimer's Disease and other tauopathies. Congratulations John!